🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is one of two replicate randomized, double-blind, placebo-controlled, ...
Status
Completed
Location
Clinical Research Of West Florida Incorporated
Start Date
2020-11-30
Trial ID
NCT04596540
Treatments Being Tested
The purpose of this study is to assess the potential for pegloticase with m...
Status
Completed
Location
University of Alabama
Start Date
2019-06-13
Trial ID
NCT03994731
The purpose of this study is to determine whether PEG-uricase (a chemically...
Status
Completed
Location
Duke University Medical Center
Start Date
2004-12
Trial ID
NCT00111657
Treatments Being Tested
Primary Objective: To evaluate safety of rasburicase in pediatric patients...
Status
Completed
Location
investigational site CHINA
Start Date
2020-05-14
Trial ID
NCT04349306
Treatments Being Tested
This is a randomized, multi-center, open-label, parallel group study with t...
Status
Completed
Location
Alta Bates Comprehensive Cancer Center
Start Date
2004-04
Trial ID
NCT00230178
Treatments Being Tested
This is a multicenter, randomized, double-blind, placebo-controlled phase I...
Status
Recruiting
Location
Applied Research Center of Arkansas
Start Date
2025-12-22
Trial ID
NCT07280156
Treatments Being Tested
The overall objective of the study is to assess the efficacy, safety, toler...
Status
Completed
Location
Orthopedic Physicians Alaska
Start Date
2018-09-26
Trial ID
NCT03635957
The goal of this clinical study is to learn if IN026 Injection is safe and ...
Status
Recruiting
Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2026-06-12
Trial ID
NCT07587684
Treatments Being Tested
Phase II trial to study the effectiveness of combining rituximab and rasbur...
Status
Completed
Location
Children's Oncology Group
Start Date
2004-06
Trial ID
NCT00057811
The purpose of this study is to determine whether the combined treatment wi...
Status
Completed
Location
Hospital General Universitario de Albacete
Start Date
2011-06
Trial ID
NCT00860366